维普期刊资源整合服务平台（V6.5）

157篇 您的检索式：作者名="JT Backman"

选中清除导出查看参考文献查看引证文献引用追踪共8页首页上一页第1页下一页末页 /8 跳转

	题名	作者	年代	出处	被引量
1	Effect of grapefruit juice dose on grapefruit juice-triazolam interaction: Repeated consumption prolongs triazolam half-life 显示文摘	Lilja JJ Kivisto KT Backman JT	2000	Eur J Clin Pharmacol2000，56，5：	1
2	Effects of the SLCOIB1 * 1B haplotype on the pharmacokinetics and pharmaeodynamies of repaglinide and nateglinide 显示文摘	Kalliokoski A Backman JT Neuvonen PJ	2008	Pharmacogenet Oenomics2008，18，11：	1
3	Pharmacokinetic interactions with rifampicin: clinical relevance 显示文摘	Niemi M Backman JT Fromm MF	2003	Clin Pharmacokinet2003，42，：	1
4	Drug interactions with lipid lowering drugs: mechanisms and clinical relevance显示文摘	Neuvonen PJ Niemi M Backman JT	2006	Clin Pharmacol Ther2006，80，6：	1
5	Polymorphic or-ganic anion transporting polypeptde 1B1 is a major determinantof repaglinide pharmacokinetics 显示文摘	Niemi M Backman JT Kajosaari LI	2005	Clin Pharmacol Ther2005，77，6：	1
6	Polymorphic organic aniontransporting polypeptide 1B1 is a major determinant of repaglinidepharmacokinetics显示文摘	Niemi M Backman JT Kajosaari LI	2005	Clin Pharmacol Ther2005，77，：	1
7	Effects ofgemfibrozil, itraconazole, and their combination on thepharmacokinetics and pharmacodynamics of repaglinide:potentially hazardous interaction between gemfibrozil andregaplinide显示文摘	Niemi M Backman JT Neuvonen M	2003	Diabetoligia2003，46，3：	1
8	Gemfibrozil is a potent inhibitor of human cytochrome P450 2C9 显示文摘	Wen X Wang JS Backman JT	2001	Drug Metab Dispos2001，29，11：	1
9	Fluvoxamine is a more potent inhibitor of lidocaine metabolism than ketoconazole and erythromycin in vitro显示文摘	Wang JS Backman JT Wen X	1999	Pharmacol Toxicol1999，85，5：	1
10	Effects of Gemfibrozil and Atorvastatin on the Pharmacokinetics of Repaglinide in Relation to SLCO1B1 Polymorphism显示文摘	A Kalliokoski JT Backman KJ Kurkinen	2008	Clinical pharmacology & Therapeutics2008，84，4：	1
11	Characterization of novel CYP2C8 haplotypes and their contribution to paclitaxel and repaglinide metabolism显示文摘	Rodriguez-Antona C Niemi M Backman JT	2007	Pharmacogenomics J2007，8，4：	1
12	Frequencies of singlenucleotide polymorphisms and haplotypes of organic anion transportingpolypeptide 1B1 SLCO1B1 gene in a Finnish population显示文摘	Pasanen MK Backman JT Neuvonen PJ	2006	Eur J ClinPharmacol2006，62，：	1
13	CYP2C8 but not CYP3A4 is important in the pharmacokinetics of montelukast 显示文摘	Karonen T Neuvonen PJ Backman JT	2012	Br J Clin Pharmacol2012，73，：	1
14	Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics 显示文摘	Niemi M Backman JT Kajosaari LI	2005	Clin Pharmacol Ther2005，77，6：	1
15	Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics and pharmacodynamics of repaglinide: potentially hazardous interaction between gemfibrozil and regaplinide显示文摘	Niemi M Backman JT Neuvonen M	2003	Diabetoligia2003，46，3：	1
16	Effects of gemfibrozil, itraconazoie, and their combination on the pharmacokineties and pharmacodynamies of repaglinide: potentially hazardous interaction be-tween gemfibrozil and repaglinide 显示文摘	Niemi M Backman JT Neuvonen M	2003	Diabetologia2003，46，3：	1
17	Gemfibrozil considerably increases the plasma concentra tions of rosiglitazone 显示文摘	Niemi M Backman JT Granfors M	2003	Diabetologia2003，46，10：	1
18	Developmental phar- macokinetics of cielosporin-a population pharmacokinetic stud- y in paediatric renal transplant candidates 显示文摘	Fanta S Jonsson S Backman JT	2007	Br J Clin Phar- macol2007，64，6：	1
19	Effects of the SLCO1B1* 1B haplotype on the pharmacokinetics and pharmacodynamics of repaglinide and nateglinide显示文摘	Kalliokoski A Backman JT Neuvonen PJ	2008	Pharmacogenet Genomics2008，18，11：	1
20	Drug interactions with lipidlowering drugs : Mechanisms and clinical relevance 显示文摘	Neuvonen PJ Niemi M Backman JT	2006	Clin Pharmacol Ther2006，80，6：	1

返回顶部每页显示：

共8页首页上一页第1页下一页末页 /8 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示